The acting head of the Food and Drug Administration is calling for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug
Related posts
-
‘We felt like rock stars’: Christmas cheer greets naval recruits in Arlington Heights
Recruits from Great Lakes Naval Station took a break from boot camp Wednesday to celebrate an... -
JOURNEYS clearing a pathway to hope for the homeless and near-homeless
JOURNEYS | The Road Home, 1140 E. Northwest Highway, helps make the days and nights easier... -
Batavia to double community surveillance measures despite privacy, cost concerns
There will be more eyes in the sky in Batavia next year as the city plans...